Anouk Schrantee - Publications

Academic Medical Center Amsterdam, Amsterdam, Netherlands 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 182528. PMID 31407970 DOI: 10.1148/radiol.2019182528  1
2019 de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, ... ... Schrantee A, et al. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. The American Journal of Psychiatry. appiajp201918101144. PMID 31352813 DOI: 10.1176/appi.ajp.2019.18101144  1
2019 Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Research. Neuroimaging. 290: 5-13. PMID 31252222 DOI: 10.1016/j.pscychresns.2019.06.005  1
2019 Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, ... ... Schrantee A, et al. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. The American Journal of Psychiatry. appiajp201918091033. PMID 31014101 DOI: 10.1176/appi.ajp.2019.18091033  1
2019 Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Journal of Psychopharmacology (Oxford, England). 269881119836229. PMID 30887865 DOI: 10.1177/0269881119836229  1
2018 Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/j.euroneuro.2018.07.099  1
2018 Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/j.nicl.2017.09.026  1
2017 Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/j.pscychresns.2017.09.009  1
2017 Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage. Clinical. 15: 812-818. PMID 28725548 DOI: 10.1016/j.nicl.2017.06.003  1
2017 Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/fj.201601234R  1
2017 Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/jce.13235  1
2017 Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. PMID 28321605 DOI: 10.1007/s11682-017-9707-x  0.68
2017 Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/journal.pone.0172776  1
2016 Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/jamapsychiatry.2016.1572  1
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/s11682-015-9419-z  1
2015 Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/npp.2014.301  1
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z  1
2014 Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48  1
2014 Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 84: 159-69. PMID 23851258 DOI: 10.1016/j.neuropharm.2013.06.029  1
2013 Perkins AM, Ettinger U, Weaver K, Schmechtig A, Schrantee A, Morrison PD, Sapara A, Kumari V, Williams SC, Corr PJ. Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Translational Psychiatry. 3: e246. PMID 23591970 DOI: 10.1038/tp.2013.20  1
2012 Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. Journal of Visualized Experiments : Jove. PMID 22565099 DOI: 10.3791/3956  1
Show low-probability matches.